Indian Patent Office to hear objections on Gilead’s HIV drug patent claims | India News
4 min read Last Updated : Sep 17 2024 | 6:15 PM IST The Indian Patent Office is set to hear objections against patent claims filed by US-based pharmaceutical giant Gilead Sciences on the HIV prevention drug ‘lenacapavir’. Sankalp Rehabilitation Trust, a civil society organisation working with vulnerable populations, argues that the patent applications … Read more